Risk Factors for Poor Adherence to Betaferon(®) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome

INTRODUCTION: Adherence to treatment, including early treatment discontinuation, in patients with multiple sclerosis or clinically isolated syndrome can be affected by: treatment tolerability, route of drug administration, patient age, disease duration, comorbidities, medical care, and support from...

Descripción completa

Detalles Bibliográficos
Autores principales: Jernas, Łukasz, Wencel, Jacek, Wiak, Andrzej, Bieniek, Marek, Bartosik-Psujek, Halina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047441/
https://www.ncbi.nlm.nih.gov/pubmed/27695075
http://dx.doi.org/10.1371/journal.pone.0157950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047441/
https://www.ncbi.nlm.nih.gov/pubmed/27695075
http://dx.doi.org/10.1371/journal.pone.0157950

Ejemplares similares